Zhengye Biotechnology Holding (ZYBT) Raw Materials (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Raw Materials for 3 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.

• Quarterly Raw Materials rose 8.17% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (up 8.17% YoY) and the FY2025 annual result came in at $1.1 million, up 11.38% from the prior year.
• Raw Materials climbed to $1.1 million in Q4 2025 per ZYBT's latest filing, from $1.0 million in the prior quarter.
• Over the last five years, Raw Materials for ZYBT reached as high as $1.4 million in Q4 2023 and fell as low as $1.0 million in Q4 2024.
• A 3-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2024 — Raw Materials dropped 24.54% — and 2025, when it gained 8.17%.
• Year by year, Raw Materials stood at $1.4 million in 2023, then slipped by 24.54% to $1.0 million in 2024, then gained by 8.17% to $1.1 million in 2025.
• According to Business Quant data, Raw Materials over the past three periods registered $1.1 million, $1.0 million, and $1.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.